Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Exicure Inc
(NQ:
XCUR
)
0.5403
+0.0006 (+0.11%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Exicure Inc
< Previous
1
2
3
4
5
6
Next >
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K
April 22, 2024
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis
February 05, 2024
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
November 28, 2023
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
August 23, 2023
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 11, 2023
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update
July 14, 2023
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives
May 26, 2023
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
May 19, 2023
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Announces Investment in Korean SNS Platform Cyworld
May 04, 2023
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
April 27, 2023
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Reports Full Year 2022 Financial Results and Provides Corporate Update
March 27, 2023
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Announces Closing of Private Placement Transaction with CBI USA, Inc. and Changes to the Board of Directors
February 24, 2023
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements
December 14, 2022
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 14, 2022
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Enters Into Definitive Agreement With CBI USA, Inc. for $5.4 Million Equity Financing and Announces Implementation of Strategic Measure to Reduce Cash Burn and Prioritize Strategic Alternatives
September 26, 2022
From
Exicure, Inc.
Via
Business Wire
Exicure Announces Presentation at Chardan’s 6th Annual Genetic Medicines Conference
September 01, 2022
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Reports Second Quarter 2022 Financial Results and Corporate Progress
August 15, 2022
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement
July 20, 2022
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split
June 29, 2022
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Announces Adjournment of Annual Meeting of Stockholders
May 27, 2022
From
Exicure, Inc.
Via
Business Wire
Exicure Announces Presentation at 2022 H.C. Wainwright Global Life Sciences Conference
May 17, 2022
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Reports First Quarter 2022 Financial Results and Corporate Progress
May 16, 2022
From
Exicure, Inc.
Via
Business Wire
Exicure Announces $5 Million Raise in Private Placement Transaction Priced at Market Premium
May 10, 2022
From
Exicure, Inc.
Via
Business Wire
Exicure to Present at Upcoming TIDES USA Oligonucleotide & Peptide Therapeutics Conference
May 09, 2022
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. (NASDAQ:XCUR) Long Term Investor Notice: Investigation of Potential Wrongdoing
April 19, 2022
San Diego, CA -- (SBWIRE) -- 04/19/2022 -- An investigation was announced for long-term investors in shares of Exicure, Inc. (NASDAQ:XCUR) concerning potential breaches of fiduciary duties by certain...
Via
SBWire
Exicure, Inc. Reports Full Year 2021 Financial Results and Corporate Progress
March 25, 2022
From
Exicure, Inc.
Via
Business Wire
Exicure Shareholder Notice
February 13, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exicure Shareholder Alert
February 11, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Final Deadline Alert: The Schall Law Firm Encourages Investors In Exicure, Inc. With Losses Of $100,000 To Contact The Firm
February 11, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Exicure, Inc. (XCUR)
February 10, 2022
From
Law Offices of Frank R. Cruz
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.